Orthopediatrics (KIDS) EBT Growth (1y) (2017 - 2026)
Orthopediatrics (KIDS) EBT Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 5.78% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 74.66% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 103.34% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -27.02% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Orthopediatrics | 443.38 Mn | 429.14 Mn | 43.39 Mn | -3.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.78% |
| Dec 31, 2025 | 40.50% |
| Sep 30, 2025 | -30.22% |
| Jun 30, 2025 | -16.82% |
| Mar 31, 2025 | -1.23% |
| Dec 31, 2024 | -137.71% |
| Sep 30, 2024 | -144.17% |
| Jun 30, 2024 | -83.97% |
| Mar 31, 2024 | -40.05% |
| Dec 31, 2023 | 12.58% |
| Sep 30, 2023 | -125.99% |
| Jun 30, 2023 | -325.78% |
| Mar 31, 2023 | 21.63% |
| Dec 31, 2022 | -4,656.63% |
| Sep 30, 2022 | 678.38% |
| Jun 30, 2022 | 80.90% |
| Mar 31, 2022 | 11.92% |
| Dec 31, 2021 | 98.87% |
| Sep 30, 2021 | 45.16% |
| Jun 30, 2021 | 57.21% |